Comprehensive Notes on Viral Pathogenicity and Virulence

Key Definitions and Fundamental Concepts

  • Pathogenicity: This term refers to the ability of a virus to cause disease in a host, which is essentially the ability to harm the host.

    • Pathogen: A virus that causes disease is categorized as a pathogen.
    • Pathogenesis: This describes the specific manner or mechanism by which a disease develops within a host.
    • Classification by Pathogenicity: Viruses are broadly categorized into Pathogenic Viruses (capable of causing disease) and Non-Pathogenic Viruses.

  • Virulence: This is a quantitative or relative measure of the degree of pathogenicity of an infecting virus.

    • Etymology: The term is derived from the Latin word "Virulentus," which translates to "full of poison" or "a poisoned wound."
    • Avirulent: A term describing a virus that is not virulent and is not harmful to the host.
    • Relative Comparison: Virulence is often compared across different strains or viruses (e.g., Virulent vs. Less Virulent vs. Avirulent).

Determinants of Virulence: The Virus-Host-Environment Tug-of-War

  • Nature of Virulence: Virulence is not an absolute property of a virus. Instead, the outcome of an infection is the result of a "Tug-of-War" involving variables from the virus, the host, and the surrounding environment.

  • Factors Related to the Virus:

    • Genetic Variation of Virus: Mutations and genetic shifts can alter how dangerous a virus is.
    • Route of Entry: The method by which the virus enters the host (e.g., skin vs. respiratory tract) affects the progression of the disease.
    • Affinity to Host Organs: The specific preference or target organs of a virus (tropism).
    • Dose of Infection: The quantity of viral particles introduced to the host.
    • Immuno-evasion: The ability of the virus to hide from or counteract the host's immune system.

  • Factors Related to the Host:

    • Host Species: Different species may have varying levels of susceptibility to the same virus.
    • Host Immunity: The strength and status of the immune system.
    • Physiological Factors: These include nutrition status, age, hormonal factors, and the stage of cell differentiation.
    • Fever: The body's innate response to infection can influence the virulence of the outcome.

  • Other Factors:

    • Environment: External conditions (temperature, humidity, etc.) can impact both virus survival and host health.
    • Dual Infections: Being infected by more than one pathogen simultaneously can exacerbate the disease.

Quantitative Measurement of Virulence (LD50LD_{50})

  • Lethal Dose 50 (LD50LD_{50}): This is defined as the dose of the virus required to cause death in 50 %50\,\% of a population of test animals, such as mice.

  • Comparative Virulence Example:

    • Strain A: LD50=30LD_{50} = 30 units.
    • Strain B: LD50=50LD_{50} = 50 units.
    • Conclusion: Virus A is more virulent than Virus B. This is because a lower dose of Virus A (3030 organisms) is required to achieve the same mortality rate (50 %50\,\%) that requires 5050 organisms of Virus B.

The Iceberg Concept and Stages of Pathogenesis

  • The Iceberg Concept of Viral Infection: This model describes the range of clinical outcomes following exposure. Most cases are at the bottom of the iceberg (subclinical), while only a few result in death.

    • Exposure without infection.
    • Subclinical infection (asymptomatic).
    • Mild disease.
    • Moderate disease.
    • Severe disease.
    • Death of the animal.

  • The Sequential Steps in Pathogenesis (The Virus's Obstacles to Success):

    1. Entry of Viruses: The initial breach of the host's defenses.
    2. Primary Replication: The first round of multiplication at the site of entry.
    3. Spread and Infection of Target Organs: Dispersion through the body to preferred tissues.
    4. Virus-Cell Interactions: How the virus impacts specific cells.
    5. Tissue and Organ Injury: The resulting physiological damage.
    6. Shedding: The release of new virions to the environment or other hosts.
    7. Host Immunity: The host's counter-attack.
    8. The "Trophy": The successful increase in the virus's "family members" (replication and transmission).

Routes of Viral Entry into the Host

  • Skin (Cutaneous Entry): Viruses enter through cuts or breaches in the skin barrier.

    • Bite of Arthropods (Transcutaneous Injection):
      • Culicoides: Transmits Bluetongue in Sheep.
      • Ticks: Transmit Louping-ill in Sheep.
      • Mosquitoes: Transmit Eastern Equine Encephalitis Virus (EEEV) in Horses.
    • Bite of Infected Animals: Transmission of Rabies.
    • Contaminated Objects: Contaminated needles can transmit Equine Infectious Anemia (EIA) or Hepatitis C Virus (HCV).

  • Mucous Membranes: Includes the Conjunctiva, Genitourinary Tract, Rectum, and Oropharynx.

    • Defenses: The mucous membranes utilize IgA (antibodies) and virucidal proteins as biological defenses.

  • Gastrointestinal (GI) Tract: Entry via contaminated food and water.

  • Respiratory Tract: Divided into Upper (Nasal cavity, Pharynx, Larynx) and Lower (Trachea, Primary bronchi, Lungs) respiratory tracts.

Mechanisms of Viral Spread within the Host

  • Local Spread on Epithelial Surfaces: The virus spreads across the epithelium, causing a localized infection. It may or may not proceed to deeper layers.

  • Subepithelial Invasion and Lymphatic Spread: Viruses overcome local host defenses to reach subepithelial tissues. Once there, they gain access to lymphatics, tissue fluids, and phagocytic cells, which can transport the virus to the bloodstream.

  • Viremia (Spread via the Bloodstream):

    • Viremia Definition: The presence of a virus in the blood.
    • Primary Viremia: The initial entry of the virus into the blood, either from subepithelial tissues/lymphatics or direct injection (needles/arthropods).
    • Secondary Viremia: This occurs after the virus has replicated in major organs and re-enters the circulatory system.

  • Disseminated vs. Systemic Infection:

    • Disseminated Infection: Infection that spreads beyond the primary site.
    • Systemic Infection: Infection involving a large number of organs or tissues.

Viral Spread via the Nervous System

  • Pathways to the Central Nervous System (CNS):

    • Peripheral Nerves: Example: Rabies virus.
    • Blood-Brain Barrier: Some viruses can cross this barrier from the blood. Example: West Nile Virus.
    • Olfactory Epithelium: Infection through receptor neurons in the nose. Example: HSV-1.

  • Specific Neural Definitions:

    • Neurotropic virus: Able to infect neural cells (via neural or hematogenous spread).
    • Neuroinvasive virus: Able to enter the CNS (brain and spinal cord) after infecting a peripheral site.
    • Neurovirulent virus: Able to cause disease in nervous tissue, often resulting in neurological symptoms or death.

  • The Trojan Horse Mechanism: Viruses use trafficking monocytes to cross the blood-brain barrier. The virus enters a monocyte in the blood vessel lumen, the monocyte crosses the blood-tissue barrier, and the virus then exits the monocyte into the brain tissue.

Viral Tropism and Cellular Interactions

  • Tropism: The affinity or specificity of a virus for a particular host tissue.

    • Enteric virus: Replicates in the gut, not the lungs.
    • Respiratory virus: Replicates in the lungs, not nerves.
    • Pantropic Viruses: These can replicate in more than one host organ or tissue.

  • Mechanisms of Viral Injury and Disease:

    • Inhibition of host-cell nucleic acid synthesis.
    • Inhibition of host-cell RNA synthesis (transcription).
    • Inhibition of host-cell protein synthesis.
    • Cytopathic effects caused by "toxic" viral proteins.
    • Interference with cellular membrane function.

Outcomes of Viral Injury to Cells

  • Cell Lysis: The host cell bursts (like a sealed popcorn bag) once replication is complete to release new virions.

  • Apoptosis: A form of programmed cell suicide activated by the host to eliminate "viral factories" before new virus production is finished. This differs from lysis because it prevents complete replication.

  • Oncoviruses (Oncogenic Viruses): Viruses that can induce cancer. Examples include Papillomavirus and Retrovirus.

  • Persistent Infection: The virus remains latent or dormant in the host cell for long periods, escaping immune detection. This may cause chronic immune stimulation resulting in immunopathology.

  • Immunosuppression:

    • Infectious Bursal Disease (IBD): Replicates in the bursa, causing atrophy and severe deficiency of B lymphocytes in birds.
    • Retroviruses: Examples like HIV, SIV, BIV, and FIV infect specific immune cells, destroying them and leaving the host susceptible to other pathogens.

Viral Shedding and Transmission

  • Importance: Shedding of infectious virions is vital for maintaining the infection in a population.
  • Acute Infection: Characterized by intensive shedding over a short duration.
  • Persistent Infection: Can involve shedding at lower titers for periods ranging from months to years.
  • Common Shedding Routes:
    • Respiratory tract.
    • Oropharynx and Gastrointestinal tract.
    • Skin.
    • Mucous membranes, oral fluids, and genital fluids.
    • Blood, urine, and milk.

Clinical Manifestations: Viral Injury to Tissues and Organs

  • Skin:

    • Localized: Papilloma (Warts).
    • Disseminated: Lumpy skin disease.
    • Vesicles: Small fluid-filled sacs, seen on the coronary band or teats in Foot and Mouth Disease (FMD).
    • Ulcers: Seen in FMD.
    • Nodules: Seen in Lumpy Skin Disease in cattle.
    • Warts: Benign skin growths caused by Papillomavirus infecting the top skin layer.
    • Erythema: Reddening of the skin caused by systemic infections and endothelial injury (e.g., Hog Cholera).

  • Gastrointestinal (GI) Tract:

    • Viruses like Rotavirus, Norovirus, Parvovirus, and Pestivirus cause destruction of intestinal enterocytes.
    • Villus Atrophy: Blunting and fusion of intestinal villi leads to malabsorption and diarrhea.
    • Consequences: Severe dehydration, Acidosis, and Hemoconcentration.

  • Respiratory Tract:

    • Viruses cause inflammation of the bronchi, leading to increased mucus and respiratory distress.
    • Symptoms: Gasping, Dyspnea (difficult breathing), and Tracheal Rales. Example: Avian Infectious Bronchitis.

  • Central Nervous System (CNS):

    • Neuronal necrosis: Death of nerve tissue.
    • Neuronophagia: Phagocytic cells devouring neuronal cells.
    • Perivascular cuffing: Accumulation of inflammatory cells around blood vessels in the CNS.
    • Demyelination: Damage to the myelin insulating layer (e.g., Canine Distemper).
    • Neuronal vacuolation: Formation of bubbles (vacuoles) in cells, seen in Prion disease.
    • Clinical Signs: Seizures, lack of coordination, unnatural postures, and hydrophobia (Rabies).

Viral Infection of the Hemopoietic System and Fetus

  • Hemopoietic System Damage:

    • Endothelium damage: Leads to hemorrhages.
    • Petechiae: Pin-point or small spots of hemorrhage.
    • Ecchymoses: Larger, ill-defined areas of hemorrhage.
    • Disseminated Intravascular Coagulation (DIC): Widespread damage to blood vessel walls leads to the formation of clots throughout the body. This exhausts clotting materials, leading to massive hemorrhaging, organ failure (due to lack of oxygen/blood), and death.

  • Fetal Infection:

    • Teratogenic Viruses: Viruses that cause developmental defects in the embryo or fetus after in-utero infection. Examples include Porencephaly and Congenital hydranencephaly caused by Bovine Viral Diarrhea Virus (BVDV).
    • Possible Outcomes: Maternal infection can lead to placental infection, fetal infection, fetal death, malformation, stillbirth, or spontaneous abortion.

Viral Immuno-Evasion Strategies

  • Negative cytokine regulation.
  • Alterations in antigen processing pathways.
  • Evasion of natural killer (NK) cells.
  • Alterations in the B cell and T cell systems.
  • Viral evasion through latency.
  • Inhibition of apoptosis.